Languages
Telescope Therapeutics leverages human-derived live-cell biosensor platforms and in silico modeling to develop disease-modifying therapies to reshape the chronic fibrotic response leading to organ failure, starting with cardiac fibrosis.
~40 % of all deaths are associated with fibrosis.
We are developing drugs that reshape the chronic fibrotic response.
Sustained fibrosis can lead to organ failure, and it is here where we want to intervene.
Heart failure remains the leading cause of death worldwide.
1–2% of total global healthcare expenditure is spent on heart failure.
Currently there is no treatment to prevent or slow down heart fibrosis.